FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2236320216> ?p ?o ?g. }

• W2236320216 abstract "Objective: Changes in carotid plaque lipid-rich necrotic core (LRNC) as assessed by magnetic resonance imaging (MRI) were investigated in subjects who continued and discontinued statin therapy for 2 years after a prospective study. Methods: The Rosuvastatin Evaluation of Atherosclerotic Chinese Patients (REACH) study in 32 lipid treatment naïve subjects with LRNC showed a significant reduction in LRNC during 24 months (M) of rosuvastatin therapy. All subjects received a clinical follow-up (F/U) visit and a repeat carotid MRI scan at 48 M as planned REACH-F/U. Despite receiving a strong recommendation to continue the statin therapy at 24 M when REACH was completed, only 15 subjects continued taking statins (rosuva.=9, simva.=4 and atorva.=2) in REACH-F/U and 17 discontinued. Lipids and LRNC, both in volume (V) and % (LRNC-V/Wall Vх100%), were compared between the statin-continued and -discontinued groups at 48 M. Results: There were no significant differences in demographic, clinical characteristics, lipids and plaque changes during 24 M in REACH between the statin-continued and -discontinued groups in REACH-F/U. Not surprisingly, at 48 M, total-Cholesterol (C), LDL-C and triglycerides were significantly lower in subjects who continued statin than those discontinued (163±43 vs. 207±30 mg/dl, p=0.002), (93±36 vs. 131±22 mg/dl, p=0.001) and (85±27 vs. 143±65 mg/dl, p=0.003), while HDL-C levels were similar. LRNC-V and %LRNC decreased significantly from 24 M in the statin-continued group (101±76 mm 3 at 24 M vs. 76±65 mm 3 at 48 M, p=0.001) and (17.3±11.9% at 24 M vs. 12.6±7.6% at 48 M, p=0.04). By contrast, subjects who discontinued statin showed non-statistically significant increase in LRNC-V and %LRNC (103±93 mm 3 at 24 M vs. 112±106 mm 3 at 48 M, p=0.4) and (15.4±11.3% at 24 M vs. 16.7±11.4% at 48 M, p=0.07). Furthermore, the changes in LRNC-V and %LRNC from 24 to 48 M were significantly different between the statin-continued and -discontinued groups in REACH-F/U (-25±18 vs. 9±14 mm 3 , p<0.001) and (-4.6±8.2 vs. 1.3±2.8%, p=0.009). Conclusion: Continued statin therapy in REACH-F/U resulted in continued decrease in LRNC, which indicates improved plaque stability. These findings provided vascular biological evidence supporting long-term statin therapy." @default.
• W2236320216 created "2016-06-24" @default.
• W2236320216 creator A5019256553 @default.
• W2236320216 creator A5034146558 @default.
• W2236320216 creator A5056353600 @default.
• W2236320216 creator A5072878232 @default.
• W2236320216 creator A5073085270 @default.
• W2236320216 date "2015-05-01" @default.
• W2236320216 modified "2023-10-16" @default.
• W2236320216 title "Abstract 708: Changes in Carotid Plaque Lipid Content in Subjects Who Continued and Discontinued Statin Therapy" @default.
• W2236320216 doi "https://doi.org/10.1161/atvb.35.suppl_1.708" @default.
• W2236320216 hasPublicationYear "2015" @default.
• W2236320216 type Work @default.
• W2236320216 sameAs 2236320216 @default.
• W2236320216 citedByCount "0" @default.
• W2236320216 crossrefType "journal-article" @default.
• W2236320216 hasAuthorship W2236320216A5019256553 @default.
• W2236320216 hasAuthorship W2236320216A5034146558 @default.
• W2236320216 hasAuthorship W2236320216A5056353600 @default.
• W2236320216 hasAuthorship W2236320216A5072878232 @default.
• W2236320216 hasAuthorship W2236320216A5073085270 @default.
• W2236320216 hasConcept C126322002 @default.
• W2236320216 hasConcept C126838900 @default.
• W2236320216 hasConcept C143409427 @default.
• W2236320216 hasConcept C164705383 @default.
• W2236320216 hasConcept C2776839432 @default.
• W2236320216 hasConcept C2779179121 @default.
• W2236320216 hasConcept C2780499067 @default.
• W2236320216 hasConcept C71924100 @default.
• W2236320216 hasConceptScore W2236320216C126322002 @default.
• W2236320216 hasConceptScore W2236320216C126838900 @default.
• W2236320216 hasConceptScore W2236320216C143409427 @default.
• W2236320216 hasConceptScore W2236320216C164705383 @default.
• W2236320216 hasConceptScore W2236320216C2776839432 @default.
• W2236320216 hasConceptScore W2236320216C2779179121 @default.
• W2236320216 hasConceptScore W2236320216C2780499067 @default.
• W2236320216 hasConceptScore W2236320216C71924100 @default.
• W2236320216 hasIssue "suppl_1" @default.
• W2236320216 hasLocation W22363202161 @default.
• W2236320216 hasOpenAccess W2236320216 @default.
• W2236320216 hasPrimaryLocation W22363202161 @default.
• W2236320216 hasRelatedWork W2101267898 @default.
• W2236320216 hasRelatedWork W2115996653 @default.
• W2236320216 hasRelatedWork W2236320216 @default.
• W2236320216 hasRelatedWork W2284854812 @default.
• W2236320216 hasRelatedWork W2794138240 @default.
• W2236320216 hasRelatedWork W2885794130 @default.
• W2236320216 hasRelatedWork W2945261979 @default.
• W2236320216 hasRelatedWork W2945408683 @default.
• W2236320216 hasRelatedWork W2972262176 @default.
• W2236320216 hasRelatedWork W3155542313 @default.
• W2236320216 hasVolume "35" @default.
• W2236320216 isParatext "false" @default.
• W2236320216 isRetracted "false" @default.
• W2236320216 magId "2236320216" @default.
• W2236320216 workType "article" @default.